Evidence map›Paper›PMID 23243496›Full record

ArticleScientific reports2012

Nuclear localization of folate receptor alpha: a new role as a transcription factor.

Vanda Boshnjaku, Kyu-Won Shim, Takao Tsurubuchi, Shunsuke Ichi, Elise V Szany, Guifa Xi, Barbara Mania-Farnell, David G McLone, Tadanori Tomita, C Shekhar Mayanil

Abstract read
In one paragraph

Article in Scientific reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Folate Receptor Alpha-A Secret Weapon in Ovarian Cancer Treatment?International journal of molecular sciences · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vanda BoshnjakuDepartment of Pediatric Neurosurgery, Ann and Robert H Lurie Children's Hospital of Chicago Research Center and Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA.
Kyu-Won Shim
Takao Tsurubuchi
Shunsuke Ichi
Elise V Szany
Guifa Xi
Barbara Mania-Farnell
David G McLone
Tadanori Tomita
C Shekhar Mayanil

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Folic acid (FA) has traditionally been associated with prevention of neural tube defects; more recent work suggests that it may also be involved in in the prevention of adult onset diseases. As the role of FA in human health and disease expands, it also becomes more critical to understand the mechanisms behind FA action. In this work we examined the hypothesis that folate receptor alpha (FRα) acts as a transcription factor. FRα is a GPI-anchored protein and a component of the caveolae fraction. The work described here shows that FRα translocates to the nucleus, where it binds to cis-regulatory elements at promoter regions of Fgfr4 and Hes1, and regulates their expression. The FRα recognition domain mapped to AT rich regions on the promoters. Until this time FRα has only been considered as a folate transporter, these studies describe a novel role for FRα as a transcription factor.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell Line, TumorCell NucleusConsensus SequenceFolate Receptor 1Folic AcidHumansMicePromoter Regions, GeneticProtein BindingReceptor, Fibroblast Growth Factor, Type 4Regulatory Elements, TranscriptionalTransfectionBasic Helix-Loop-Helix ProteinsFgfr4 protein, mouseFolate Receptor 1Folic AcidReceptor, Fibroblast Growth Factor, Type 4

Identifiers

PMID23243496
PMCPMC3522071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.